Literature DB >> 33809530

PharmaKU: A Web-Based Tool Aimed at Improving Outreach and Clinical Utility of Pharmacogenomics.

Sumi Elsa John1, Arshad Mohamed Channanath1, Prashantha Hebbar1, Rasheeba Nizam1, Thangavel Alphonse Thanaraj1, Fahd Al-Mulla1.   

Abstract

With the tremendous advancements in genome sequencing technology in the field of pharmacogenomics, data have to be made accessible to be more efficiently utilized by broader clinical disciplines. Physicians who require the drug-genome interactome information, have been challenged by the complicated pharmacogenomic star-based classification system. We present here an end-to-end web-based pharmacogenomics tool, PharmaKU, which has a comprehensive easy-to-use interface. PharmaKU can help to overcome several hurdles posed by previous pharmacogenomics tools, including input in hg38 format only, while hg19/GRCh37 is now the most popular reference genome assembly among clinicians and geneticists, as well as the lack of clinical recommendations and other pertinent dosage-related information. This tool extracts genetic variants from nine well-annotated pharmacogenes (for which diplotype to phenotype information is available) from whole genome variant files and uses Stargazer software to assign diplotypes and apply prescribing recommendations from pharmacogenomic resources. The tool is wrapped with a user-friendly web interface, which allows for choosing hg19 or hg38 as the reference genome version and reports results as a comprehensive PDF document. PharmaKU is anticipated to enable bench to bedside implementation of pharmacogenomics knowledge by bringing precision medicine closer to a clinical reality.

Entities:  

Keywords:  bioinformatics; dosage recommendation; genomics; next-generation sequencing; pharmacogenomics; precision medicine; star alleles; whole genome sequencing

Year:  2021        PMID: 33809530      PMCID: PMC7998233          DOI: 10.3390/jpm11030210

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  45 in total

1.  Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.

Authors:  Victoria M Pratt; Barbara Zehnbauer; Jean Amos Wilson; Ruth Baak; Nikolina Babic; Maria Bettinotti; Arlene Buller; Ken Butz; Matthew Campbell; Chris Civalier; Abdalla El-Badry; Daniel H Farkas; Elaine Lyon; Saptarshi Mandal; Jason McKinney; Kasinathan Muralidharan; LeAnne Noll; Tara Sander; Junaid Shabbeer; Chingying Smith; Milhan Telatar; Lorraine Toji; Anand Vairavan; Carlos Vance; Karen E Weck; Alan H B Wu; Kiang-Teck J Yeo; Markus Zeller; Lisa Kalman
Journal:  J Mol Diagn       Date:  2010-10-01       Impact factor: 5.568

2.  Pharmacogenetics at 50: genomic personalization comes of age.

Authors:  Thomas J Urban; David B Goldstein
Journal:  Sci Transl Med       Date:  2014-01-22       Impact factor: 17.956

Review 3.  Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.

Authors:  Sheila Riazi; Natalia Kraeva; Philip M Hopkins
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

4.  Challenges in the pharmacogenomic annotation of whole genomes.

Authors:  R B Altman; M Whirl-Carrillo; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2013-05-24       Impact factor: 6.875

5.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients.

Authors:  Munir Pirmohamed; Sally James; Shaun Meakin; Chris Green; Andrew K Scott; Thomas J Walley; Keith Farrar; B Kevin Park; Alasdair M Breckenridge
Journal:  BMJ       Date:  2004-07-03

6.  Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes.

Authors:  Ibrahim Numanagić; Salem Malikić; Michael Ford; Xiang Qin; Lorraine Toji; Milan Radovich; Todd C Skaar; Victoria M Pratt; Bonnie Berger; Steve Scherer; S Cenk Sahinalp
Journal:  Nat Commun       Date:  2018-02-26       Impact factor: 14.919

Review 7.  Integrating Next-Generation Sequencing in the Clinical Pharmacogenomics Workflow.

Authors:  Efstathia Giannopoulou; Theodora Katsila; Christina Mitropoulou; Evangelia-Eirini Tsermpini; George P Patrinos
Journal:  Front Pharmacol       Date:  2019-04-05       Impact factor: 5.810

8.  Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics.

Authors:  Maria-Theodora Pandi; Marc S Williams; Peter van der Spek; Maria Koromina; George P Patrinos
Journal:  Genes (Basel)       Date:  2020-05-18       Impact factor: 4.096

9.  Development and use of active clinical decision support for preemptive pharmacogenomics.

Authors:  Gillian C Bell; Kristine R Crews; Mark R Wilkinson; Cyrine E Haidar; J Kevin Hicks; Donald K Baker; Nancy M Kornegay; Wenjian Yang; Shane J Cross; Scott C Howard; Robert R Freimuth; William E Evans; Ulrich Broeckel; Mary V Relling; James M Hoffman
Journal:  J Am Med Inform Assoc       Date:  2013-08-26       Impact factor: 4.497

10.  PharmCAT: A Pharmacogenomics Clinical Annotation Tool.

Authors:  Teri E Klein; Marylyn D Ritchie
Journal:  Clin Pharmacol Ther       Date:  2017-12-01       Impact factor: 6.875

View more
  1 in total

1.  A blockchain-based framework to support pharmacogenetic data sharing.

Authors:  F Albalwy; J H McDermott; W G Newman; A Brass; A Davies
Journal:  Pharmacogenomics J       Date:  2022-07-22       Impact factor: 3.245

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.